Sernova Corp. is a clinical-stage biotechnology company developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders, such as hemophilia A. Sernova is currently focused on developing a ‘functional cure’ for insulin-dependent diabetes with its lead asset, the Cell Pouch System™, in collaboration with Evotec SE since entering into a global strategic partnership with the use of Evotec’s induced pluripotent stem cell (iPSC)-derived pancreatic islet-like clusters (ILCs) with the Cell Pouch System.

Sernova logo



Event details

Date: June 5 - 8, 2023

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


33 in total